Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 18, Pages -Publisher
MDPI
DOI: 10.3390/ijms22189769
Keywords
epilepsy; variant; protocadherin; hormones; nuclear hormone receptor; neurosteroids; estrogen receptors; progesterone receptor; androgen receptor
Funding
- NHMRC [APP1155224, APP1091593]
Ask authors/readers for more resources
The variants of PCDH19 gene have been linked to early-onset developmental epileptic encephalopathy clustering epilepsy, with alterations in steroidogenesis and NHR-related gene expression in affected individuals. The effectiveness of steroid-based antiepileptic drugs in treating this disorder remains uncertain, calling for further research.
Steroids yield great influence on neurological development through nuclear hormone receptor (NHR)-mediated gene regulation. We recently reported that cell adhesion molecule protocadherin 19 (encoded by the PCDH19 gene) is involved in the coregulation of steroid receptor activity on gene expression. PCDH19 variants cause early-onset developmental epileptic encephalopathy clustering epilepsy (CE), with altered steroidogenesis and NHR-related gene expression being identified in these individuals. The implication of hormonal pathways in CE pathogenesis has led to the investigation of various steroid-based antiepileptic drugs in the treatment of this disorder, with mixed results so far. Therefore, there are many unmet challenges in assessing the antiseizure targets and efficiency of steroid-based therapeutics for CE. We review and assess the evidence for and against the implication of neurosteroids in the pathogenesis of CE and in view of their possible clinical benefit.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available